학술논문

Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study
Document Type
Article
Source
In: European Journal of Cancer. (European Journal of Cancer, May 2024, 203)
Subject
Language
English
ISSN
18790852
09598049